PHYSIONEAL 40 DEXTROSE SOLUTION 4.25% w/v/ 42.5 mg/ml

BAXTER HEALTHCARE (ASIA) PTE LTD

BAXTER HEALTHCARE (ASIA) PTE LTD

Therapeutic

General Sale List

SOLUTION, STERILE

**4.2 Posology and method of administration** - PHYSIONEAL 40 is intended for intraperitoneal administration only. Not for intravenous administration. - Peritoneal dialysis solutions may be warmed to 37°C (98.6°F) to enhance patient comfort. However, only dry heat (for example, heating pad, warming plate) should be used. Solutions should not be heated in water or in a microwave oven due to the potential for patient injury or discomfort. - The solution should be warmed in the overpouch to body temperature before use. - After removal of the overpouch, immediately break the interchamber frangible pin to mix the two solutions. Wait until the upper chamber has completely drained into the lower chamber. Mix gently by pushing with both hands on the lower chamber walls. The intraperitoneal solution must be infused within 24 hours after mixing. - Aseptic technique should be employed throughout the peritoneal dialysis procedure. - The mode of therapy, frequency of treatment, exchange volume, duration of dwell and length of dialysis should be selected by the physician. - To avoid the risk of severe dehydration, hypovolemia and to minimise the loss of proteins, it is advisable to select the peritoneal dialysis solution with the lowest level of osmolarity consistent with fluid removal requirements for each exchange. PHYSIONEAL 40 Dextrose 4.25% w/v Solution for Peritoneal Dialysis is a high osmotic pressure fluid and using it for all exchanges may cause dehydration. - The average frequency is 4 to 5 times a day. The fill volume depends on body size, usually from 2.0 to 2.5 liters. - So far, there are no data from clinical studies in pediatric patients. In this patient category the benefits of PHYSIONEAL 40 have therefore to be balanced versus the risk of side effects. - More than 30% of the patients in the clinical trials were older than 65. The evaluation of the results obtained for this group does not show any difference to the rest of the patients.